BD Issues Safety Notice for Alaris neXus V700 Infusion Pump System in the UK

Becton Dickinson (BD), a leading medical technology company, has urgently issued a field safety notice in the UK regarding potential issues with its Alaris neXus V700 infusion pump system.

According to the notice, BD has identified a concern where the anti-free flow clamp on the pump may not activate when the system door is opened, potentially leading to uncontrolled medication flow.

The company warns that this issue could result in over-infusion and life-threatening situations, depending on the medication being administered through the pump. An adverse event has already been reported in relation to this problem.

As a response, BD has instructed clinicians to immediately stop using the neXus V700 infusion pumps and quarantine them until further instructions are received from the legal manufacturer, Medcaptain Medical Technology.

The Alaris neXus platform is designed to enhance infusion safety with features like Guardrails safety software and Wi-Fi connectivity, aiming to prevent medication errors in various hospital care settings.

This development adds to the ongoing challenges faced by medical device manufacturers in ensuring the safety and effectiveness of their products.